First Patient Dosed with Gadeta’s gamma delta TCR Cell Therapy
A new milestone for Gadeta, one of Utrecht Holdings portfolio companies! Below the press release: GDT-002 is a potential first-in-class cellular immunotherapy UTRECHT, Netherlands and BOSTON, July 6, 2021 /PRNewswire/ — Gadeta B.V., a clinical-stage…